Search published articles

Showing 4 results for Ahmad Reza

Shahabedin Sadr, Ahmad Reza Dehpour, Namdar Yousofvand, Farokh Shadan, Abbas Norouzi,
Volume 6, Issue 1 (Spring and Summer 2002)

In this study, the effect of various doses of ouabain (1, 2, and 5 mg/kg, i.p.) on weight and flow rate of submandibular gland (SMG) and changes in zinc and copper levels in pure saliva and serum of rats was investigated. The time interval between injection of drug and sampling was 30 min. In addition, the effect of a single and toxic dose of ouabain (5 mg/kg, i.p.) in various time intervals (30 min, 1, 2, 3, 7, and 14 days) was also studied. The results showed that in all groups, normalized weight of SMG did not differ significantly. Meanwhile, flow rate decreased 30 min after injection in those animals receiving 2 and 5 mg/kg ouabain and one day after injection in the group receiving 5 mg/kg ouabain. After this time period, all flow rates recovered. In addition, level of zinc increased in serum and saliva in those groups receiving 2 and 5 mg/kg ouabain after 30 min, but it decreased in the group receiving 1 mg/kg of the drug and in recovered groups after 2, 3, and 7 days, serum zinc concentration showed a negligible elevation. Further analysis of data showed that there was no correlation between serum and salivary copper levels. In this respect, only salivary copper level decreased in groups receiving 1, 2, and 5 mg/kg of ouabain and in recovered group after 1 day, whereas copper level only decreased in serum in groups receiving ouabain after 2, 3, and 7 days. Therefore, alterations in zinc level correlate with the inhibitory effects of ouabain on sodium-potassium pump, which may also be the mechanism responsible for the uptake or transport of zinc in this gland. It is noteworthy that alterations in zinc and copper level were opposite of each other in saliva of groups receiving 2 and 5 mg/kg of ouabain and in recovery groups and also in the serum obtained from recovery groups. Taken together, it seems that a period of 14 days is enough for recovery from all of the changes due to the toxic doses of ouabain.
Seyed Shahabedin Sadr, Ahmad Reza Dehpour, Fatemeh Mirershadi,
Volume 7, Issue 2 (Fall and Winter 2003)

Considering the clinical significance of opioids, especially their application for the treatment of severe painful conditions including cancer pain and the requirement for the synthesis of more specific drugs with lower side effects, this study was conducted to perform a preliminary investigation on six newly developed opioid drugs. Our aim was to introduce drugs that act selectively on the opioid µ or δ receptors. Since the inhibitory effect of the opioids on the smooth muscle ceIls has already been proved, we have decided to investigate the inhibitory effect of new drugs in this family on the contraction of guinea pig ileum and mouse vas deferens. Each drug was tested for 6 times and the results were evaluated through comparing their IC50 with morphine and with other drugs regarding MVDIC50/GPI IC50 Ratio. The results showed that ail new drugs have inhibitory effects on the muscle twitch, which indicates their agonistic property. Secondly, the new drugs were more selective for µ receptors than δ ones. Third, drug F in guinea pig didn't produce any significant effect in comparison with morphine, but the observed difference for drugs A, B, C, D, and E were significant as compared to morphine. Furthermore, all of them had significant effect on mouse vas deferens in comparison with morphine
Tara Dehpour, Mani Ali Reza, Shahram Ejtemaeimehr, Dehpour Ahmad Reza,
Volume 10, Issue 2 (Summer 2006)

Mohammad Amin Edalatmanesh, Ahmad Reza Bahrami, Morteza Behnam Rasuli, Ali Moghimi, Maryam Moghadam Matin, Fatemeh Naseri,
Volume 12, Issue 3 (Fall 2008)

Introduction: As an inherited neurodegenerative disease, Huntington's disease is accompanied with wide neuronal degeneration in neostriatum and neocortex. Progress of the disease causes disabling clinical effects on movements, recognition and physiology of the body, and finally results in death. At this stage of knowledge we are, there is no effective therapeutic strategy for diminishing the motor disorders of Huntington's disease. In recent years, cellular transplantation has been an effective therapeutic method for neurodegenerative disease. Material and methods: In this paper, the effects of bone marrow derived mesenchymal stem cells were assessed in animal model of Huntington disease. After causing ipsilateral lesion in striatum with Quinolinic acid, bone marrowe derived mesenchymal stem cells which had been isolated and purified from 4-6 weeks old rats, transplanted into damage striatum. The efficiency of cellular transplantation for improvement of motor disorder was assessed by cylinder test and Apomorphin induced rotation tests, during eight weeks after engraftment. Results: Results show significant improvement (p ≤ 0.0001) in motor disorders and striatal atrophy percent. Conclision: According to results of this assay, cell therapy by means of bone marrow derived adult stem cells promises for treatment of neurodegenerative diseases, especially Huntington's disease.

Page 1 from 1